Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is an international, randomized, double-blind, placebo-controlled trial to evaluate the
clinical efficacy of palifosfamide-tris administered with doxorubicin in combination,
compared with doxorubicin administered with placebo in front-line patients diagnosed with
metastatic soft tissue sarcoma (STS).